DOCSLIB.ORG

Normal Laboratory Values/Adult Patients

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Normal Laboratory Values/Adult Patients Normal Laboratory Values/Adult Patients Clinical Chemistry Tests Lipid Panel Alanine aminotransferase 13–48 U/L Cholesterol, total 160–240 mg/dL (ALT, SGPT) HDL cholesterol >40 mg/dL Albumin 3.6–5.2 g/dL LDL cholesterol <130 mg/dL Alkaline phosphatase (ALP) 35–120 U/L Triglycerides 55–200 mg/dL Amylase, serum 44–128 U/L Aspartate aminotransferase 15–41 U/L (AST, SGOT) Bilirubin, conjugated 0–0.2 mg/dL Thyroid Function Tests Bilirubin, total 0.2–1.2 mg/dL Thyroid stimulating hormone (TSH) 2–11 μU/mL Calcium 8.5–10.5 mg/dL Thyroxine, free (FT4) 0.8–2.4 ng/dL Carbon dioxide (CO2), total 23–30 mEq/L Thyroxine, total (T ) 4.0–12.0 μg/dL Chloride 98–109 mEq/L 4 Triiodothyronine (T )70–200 ng/dL Creatine kinase (CK, CPK) 40–260 U/L 3 Triiodothyronine (T ) resin uptake 25–38% Creatinine 0.7–1.2 mg/dL 3 (T3RU) Gamma glutamyltransferase 5–40 U/L (GGT) Glucose, fasting 65–110 mg/dL Hemoglobin A1C 5.0–7.0% of total Hb Blood Gases Iron, serum 50–170 μg/dL Iron-binding capacity, total 270–390 μg/dL Arterial Venous (TIBC) Base excess À3.0 to À5.0 to Lactate, serum (venous) 5.0–20.0 mg/dL +3.0 mEq/L +5.0 mEq/L Lactate dehydrogenase (LDH) 110–260 U/L Bicarbonate 18–25 mEq/L 18–25 mEq/L Lipase 10–140 U/L (HCO3) – – Magnesium 1.5–2.5 mg/dL pO2 80 95 mm Hg 30 48 mm Hg – – Potassium 3.5–5.1 mEq/L O2 saturation 95 98 % 60 85 % – – Prostate-specific antigen 0–4 ng/mL pCO2 34 45 mm Hg 35 52 mm Hg – – Protein, total 6.1–7.9 g/dL Total CO2 23 30 mEq/L 24 31 mEq/L – – Sodium 136–147 mEq/L pH 7.35 7.45 7.32 7.42 Troponin I <2.5 ng/mL Troponin T <0.2 ng/mL Urea nitrogen 6.0–20.0 mg/dL Hematology and Coagulation Tests Uric acid 2.6–7.2 mg/dL White blood cell (WBC) 4.4–11.0 K/mm3 count Hemoglobin 12.2–15.0 g/dL (continued) # Springer International Publishing Switzerland 2017 1811 P.M. Paulman et al. (eds.), Family Medicine, DOI 10.1007/978-3-319-04414-9 1812 Normal Laboratory Values/Adult Patients Hematocrit 37.0–54.0 % Eosinophils 0–5% Red blood cell (RBC) count 3.80–5.20 million/mm3 Basophils 0–2% Mean corpuscular volume 85.0–95.0 μm3 Sedimentation rate (MCV) Adult male 15 mm/hr Mean corpuscular 26.0–34.0 pg/cell Adult female 20 mm/hr hemoglobin (MCH) Coagulation tests – MCH concentration 32.6 36.0 g/dL Fibrinogen 200–400 mg/dL (MCHC) Partial thromboplastin time 60–85 seconds – Red cell distribution width 11.5 15.0 % (PTT) (RDW) Activated PTT 25–35 seconds Platelet count 150.0–420.0 K/mm3 Prothrombin time (PT) 11–14 seconds Reticulocyte count 0.5–1.5 % of RBCs Note: The reference intervals shown are for adults and may WBC differential vary according to technique or laboratory, or as new – Neutrophils 38 70 % methods are introduced. Always consult the reference Lymphocytes 16–49 % range for your own laboratory. Monocytes 2–9% (continued) Index A respiratory acidosis, 1267–1268 ABCDE rules, 1605 respiratory alkalosis, 1266–1267 ABCX family crisis model, 390 AC joint arthritis, 1474–1475 ABCX model, 391 Acne, 1570–1572 Abdominal aortic aneurysms (AAA), 89 fulminans, 1571 Abdominal pain, 1160 inversa, 1573–1574 Abdominal pathology, patient evaluation ACOG, 158 history, 1212–1213 Acquired immunodeficiency syndrome (AIDS), 563, 870 imaging, 1214–1215 Acquired renal cystic disease, 1289 laboratory testing, 1214 Acrodermatitis chronica atrophicans, 573 physical examination, 1213–1214 ACTH stimulation, 1708 Abdominal radiation, 1203 Actinic keratosis, 1603–1604 Abdominal trauma Actinic lentigo, 1606 background, 1217–1218 Action to Control Cardiovascular Risk Reduction diagnosis, 1218 (ACCORD) trial, 1652, 1656, 1657 management, 1218–1219 Activated charcoal, 616–617 Abetalipoproteinemia, 1639 Active listening, 713 Ablation therapy, 990, 994 Active suicidal ideations, 441 Abnormal uterine bleeding, 1371, 1375–1379 Activities of daily living (ADL), 306 Abnormalities in vital signs, 460–461 Acupuncture, 420, 767, 1392, 1466, 1780–1781 Absence epilepsy, 825 Acute abdomen, 1212 Absent breast tissue, 1418 Acute abdominal pain, 1212 Absolute reticulocyte count, 1723 Acute abnormal uterine bleeding, 1371 Absolute risk reduction, 52 Acute angle-closure glaucoma, 923 Abstinence, 541 Acute back pain, 682–683 Abuse, 388 Acute bacterial prostatitis, 1299 Acalculous cholecystitis, 1223 Acute bacterial rhinosinusitis (ABRS), 242 Acamprosate, 767 Acute bilirubin encephalopathy, 223 Accommodation loss. See Presbyopia Acute bronchiolitis, 244 Accountable Care Organization (ACO), 61, 1788 Acute bronchitis, 513–514 Accreditation Council for Graduate Medical Education, Acute cervical strain, 1468–1469 1768 Acute closed angle glaucoma, 899–900 Accutane, 1572 Acute coronary syndrome (ACS), 974, 976–978, 1066 ACE inhibitors, 968–969, 1073, 1289 Acute cystitis, 154 Acetabular labral tear (ALT), 1498 Acute gastroenteritis, 250–251 Acetaminophen (APAP), 618–621, 1519 Acute headaches, 881 Achilles tendon, 1505 Acute heart failure syndrome (AHFS), 1025–1026 Achilles tendon rupture, 692, 1508–1509 Acute interstitial nephritis, 503, 1284 Achilles tendonopathy, 692 Acute kidney injury (AKI) Acholic stools, 1163 definition, 1283 Acid base disorders postrenal, 1284–1285 metabolic acidosis, 1264–1266 prerenal, 1283–1284 metabolic alkalosis, 1267 prevention and treatment, 1285–1286 mixed acid–base disturbance, 1268–1270 risk factors, 1285 # Springer International Publishing Switzerland 2017 1813 P.M. Paulman et al. (eds.), Family Medicine, DOI 10.1007/978-3-319-04414-9 1814 Index Acute lacerations Adenoviral conjunctivitis, 894 anesthesia, 635–638 Adenoviruses, 892, 1144, 1235 antibiotics, 646–647 ADHD. See Attention deficit/hyperactivity disorder coding and billing, 647–648 (ADHD) indications/contraindications to primary closure, ADHD-predominately hyperactive/impulsive, 256 634–635 fidgety, 256 principles and techniques, wound closure, 639–643 interrupts, 256 skin anatomy and wound healing, 634 restless, 256 suture characteristics, 639, 640 talkative, 256 wound care and follow up, 647 Adhesive capsulitis, 1477 wound closure, 634 Adhesive strips, 645, 646 wound preparation and assessment, 638–639 Adipose tissue, 701 Acute limb ischemia, 1052 Adiposity, 701 Acute mesenteric ischemia, 1236 Adjunctive therapies, 521–522 Acute orchitis, 1323 Adjunctive treatment, 524 Acute otitis media (AOM), 244–246 Adjustment disorder, 416 causes, 929 Adjuvant therapy, 704 complications, 931 Adnexal torsion, 1439 diagnosis, 929–930 Adolescence stage epidemiology, 929 driving, 20 prevention, 931 puberty, 19, 20 treatment, 930–931 sexual identity and development, 20 Acute pain, 788 substance use, 19–20 Acute pancreatitis, 1158, 1463 Adolescent acne, 1571 Acute pelvic pain Adolescents, 101–103, 722 definition, 1436 anticipatory guidance, 300 diagnosis, 1437 confidentiality, 295 gastrointestinal disorders, 1439 emotional maturity, 296 history, 1436 immunizations, 299 imaging modalities, 1437 physical examination, 299 infectious gynecologic causes of, 1437–1438 psychosocial health issues, 297 laboratory analysis, 1436–1437 sexual development, 299 noninfectious gynecologic causes of, 1438–1439 Adrenarche, 1706 physical exam, 1436 Adult cardiovascular life support (ACLS) program, 840 pregnancy risk, 1437 Adult hearing loss, 948–949 urinary tract disorders, 1439–1440 conductive hearing loss, 948 Acute pericarditis, 1053–1054 evaluation and diagnosis, 948–949 Acute poststreptococcal glomerulonephritis, 524 prevention, 949 Acute proliferative glomerulonephritis, 1276 sensorineural hearing loss, 948 Acute respiratory distress syndrome (ARDS), treatment, 949 1112–1114 Adult Protective Services (APS), 351 Acute rheumatic fever, 524 Adult vaccination, 83 Acute rhinosinusitis, 520 Advance and cut technique, 662–663 Acute risk, 444 Advance directive, 345 Acute SMA occlusion, 1236 Advanced adenomas, 1201 Acute somatization Advanced directives, 802–803 social support, 453 Advanced lipid tests, 1641 stress-related symptoms, 453 Advanced maternal age, 161–162 Acute stress disorder, 412, 416 Adverse Events Reporting System (VAERS), 75 Acute urinary retention, 1298 Advisory Committee on Immunization Practices (ACIP), Acute urticaria, 1577 74, 84 Acyclovir (Zovirax), 156, 540, 877 Aerobic exercise, 1550, 1655 Adaptive immune responses, 508 Affective deficits, 559 Addison disease, 1710 African-American men, 1103 Adenocarcinoma, 1106 Age-adjusted D-dimer, 1045 Adenohypophysis, 1702 Agency for Healthcare Research and Quality (AHRQ), Adenoma detection rate (ADR), 1205 74, 1762 Adenomas, 1200 Aging, 722 Adenomyosis, 1443 Agitation, 344 Index 1815 Agoraphobia, 413, 414 5α-reductase inhibitors, 1298 AIDS. See Acquired immunodeficiency syndrome Alpha thalassemia trait, 1726 (AIDS) Alprazolam, 857 Air bronchograms, 221 Altemeier procedure, 1191 Air pollution, 1104 Altered sleep, 476 Akinesia, 852 Alveolitis, 1120 Alanine aminotransferase, 1167 Alzheimer’s disease, 853, 1641 Albendazole, 252, 568, 570, 1143 Amantadine (Symmetrel), 854–856 Alcohol, 72, 78, 83, 87, 162, 1158, 1160–1163 Amaurosis fugax, 921 Alcohol abuse, 40 Amblyopia, 924 Alcohol consumption, 1202 Ambulatory blood pressure monitoring, 971 Alcohol septal ablation, 1062 Amenorrhea, 142, 460, 1213, 1371, 1383 Alcohol use disorder (AUD), 414, 755 American Academy of Family Physicians (AAFP), diagnosis, 756–757 1428, 1793 prevalence, 756 American Academy of Pediatrics (AAP), 1314 screening, 756 American Association of Clinical Endocrinologists treatment, 757–759 (AACE), 1653 Alcohol Use Disorders Identification Test (AUDIT), 756 American Board of Family Medicine, 41 Alcohol withdrawal syndrome (AWS) The American Board of Family Practice (ABFP), 5 DT management, 763 American Board of Medical
Load more

Recommended publications
  • A Review of Delusions of Parasitosis, Part 1: Presentation and Diagnosis
    CONTINUING MEDICAL EDUCATION A Review of Delusions of Parasitosis, Part 1: Presentation and Diagnosis Rachel Bak, MD; Phani Tumu, MD; Christina Hui, MD; David Kay, BA; Julie Burnett; David Peng, MD GOAL To understand delusions of parasitosis (DOP) to better manage patients with the condition OBJECTIVES Upon completion of this activity, dermatologists and general practitioners should be able to: 1. Identify criteria for diagnosing DOP. 2. Describe features associated with DOP. 3. Discuss possible causes of DOP. CME Test on page 136. This article has been peer reviewed and approved Einstein College of Medicine is accredited by by Michael Fisher, MD, Professor of Medicine, the ACCME to provide continuing medical edu- Albert Einstein College of Medicine. Review date: cation for physicians. July 2008. Albert Einstein College of Medicine designates This activity has been planned and imple- this educational activity for a maximum of 1 AMA mented in accordance with the Essential Areas PRA Category 1 CreditTM. Physicians should only and Policies of the Accreditation Council for claim credit commensurate with the extent of their Continuing Medical Education through the participation in the activity. joint sponsorship of Albert Einstein College of This activity has been planned and produced in Medicine and Quadrant HealthCom, Inc. Albert accordance with ACCME Essentials. Drs. Bak, Tumu, Hui, and Peng; Mr. Kay; and Ms. Burnett report no conflict of interest. The authors report no discussion of off-label use. Dr. Fisher reports no conflict of interest. Delusions of parasitosis (DOP), a psychiatric and treatment with psychotropic medications. We disorder in which patients erroneously insist discuss the classification, epidemiology, clinical that they are infested with parasites, remains a presentation, etiology, associated features, and fascinating entity with elusive origins.
    [Show full text]
  • PERAN PSIKONEUROALERGOLOGI PADA DERMATOLOGI Dr. Dr. Cita
    PERAN PSIKONEUROALERGOLOGI PADA DERMATOLOGI Dr. dr. Cita Rosita Sigit Prakoeswa, Sp.KK(K), FINSDV, FAADV Bagian Kulit dan Kelamin FK UNAIR/RSUD Dr Soetomo Surabaya Abstrak Psikoneuroimunologi adalah sebuah interdisiplin ilmu dengan fokus komunikasi biokimia antara otak, perilaku dan sistem imun. Psikoneuroalergologi merupakan turunan Psikoneuroimunologi yang lebih memfokuskan pada keterkaitan alergi imunologi dengan faktor psikososial. Peningkatan manifestasi alergi diduga berhubungan dengan faktor-faktor lingkungan seperti stres. Berbagai penelitian telah dilakukan dan terbukti adanya disfungsi hipotalamus- hipofisis-adrenal (HPA) dalam respon terhadap stres dapat memfasilitasi penyimpangan sistem imun dan dengan demikian, dapat meningkatkan risiko sensitisasi dan eksaserbasi alergi terutama dalam kondisi stres. Secara klinis dan fisiologis telah dapat dijelaskan mengenai stres psikologis yang merupakan kontributor penting pada perjalanan penyakit alergi melalui efeknya secara langsung maupun tidak langsung terhadap respon imun, ekspresi neuropeptide kulit, dan fungsi sawar kulit. Kata kunci: psikoneuroimunologi, psikoneuroalergologi, hipotalamus-hipofisis-adrenal Abstract Psychoneuroimmunology is an inter disiplinary field that specifically examines the biochemical cross talk between brain, behavior and the immune system. Psychoneuroallergology at the cross road between allergy immunology concept and psycosocial factors. The increase of allergic manifestation may be associated with environmental factors such as stress. A growing number
    [Show full text]
  • Hi There, Spooky Family! Before I Begin, I’D Like to Apologise for Reading from Notes I Prepared Beforehand
    Hi there, Spooky family! Before I begin, I’d like to apologise for reading from notes I prepared beforehand. I’m afraid my memory is not as young as it used to be, and to embark on a talk of this length without a memory aid would be very difficult for me to even attempt now. If you saw John White’s SAMA webinar on biofeedback last week, you’ll be aware that I’m presently in China right now for reasons that will be shared with you all later in the year. So with Echo’s encouragement, by which I really mean prodding, I thought I’d take the opportunity to talk about myself - my least favourite subject by a country mile! You’ve probably noticed that my initials - DB - appear in the titles of many of the Spooky2 factory presets. Feedback from Spooky2 users tells us that our presets work very effectively, and our thousands of testimonials give very powerful witness to that. For this, we must thank our expert preset builders - John White (JW), Jeff Kaczor (JK), Bryan Yamamoto (BY), Manuel Mallo (MM), Walt Dod (WD), Ed Von (EV), and David Halliday (DH). I think almost all of our preset builders knew quite a bit about Rife therapy when Spooky was launched. And John White had actually designed and built several Rife machines before starting his Spooky journey. I, pn the other hand, will freely admit that I knew virtually nothing about Rife beyond the fact that it worked. When my first Spooky rig arrived on my doorstep, I was completely bamboozled, and I had to make several posts on the forum we used at that time to seek help on how to connect it, then set everything up correctly.
    [Show full text]
  • How to Get Your Life Back from Morgellons, Chronic Lyme, and Other Skin Parasites Limited Edition
    How to Get Your Life Back from Morgellons, Chronic Lyme, and Other Skin Parasites Limited Edition Unraveling the Connection Between Chronic Lyme & Morgellons By Richard Kuhns B.S.Ch.E. Tenth Printing Self Published 2006, 2011, 2012, 2014, 2015, 2016, 2017, 2020 By Get Your Life Back LLC 28 Tindall Rd. Middletown, NJ 07748 732-531-1178 1-800-993-0929 Cover art by Jonquelyne Kalmbach King DietSM is a service mark owned by Get Your Life Back LLC Middletown, NJ Nature's Gift® is a registered trade mark owned by Get Your Life Back LLC Middletown, NJ This book may not be reproduced or transmitted in whole or in part through any means electronic or mechanical including photo copying or electronic transmission without prior written permission from the author, except as considered normal for review. Disclaimer and Terms of Use: The Author and Publisher has striven to be as accurate and complete as possible in the creation of this book, notwithstanding the fact that he does not warrant or represent at any time that the contents within are accurate due to the rapidly changing nature of the subject matter. While all attempts have been made to verify information provided in this publication, the Author and Publisher assumes no responsibility for errors, omissions, or contrary interpretation of the subject matter herein. Any perceived slights of specific persons, peoples, or organizations are unintentional. In practical advice books, like anything else in life, there are no guarantees. Note: the FDA has not evaluated the information contained in this book. This information is for educational purposes only.
    [Show full text]
  • {Replace with the Title of Your Dissertation}
    Power Shifts: How Patient Activism Shapes the Practice of Medicine A DISSERTATION SUBMITTED TO THE FACULTY OF THE GRADUATE SCHOOL OF THE UNIVERSITY OF MINNESOTA BY Susan Parry IN PARTIAL FULFILLMENT OF THE REQUIREMENTS FOR THE DEGREE OF DOCTOR OF PHILOSOPHY Carl Elliott, Adviser November 2008 © Susan Parry 2008 i Acknowledgements I would like to thank my committee members Carl Elliott, Debra DeBruin, Jeff Kahn, and Valerie Tiberius, all of whom have been invaluable mentors and friends. Carl Elliott, my adviser, has been helpful and supportive beyond measure. I have had the pleasure of spending most of my time in graduate school at the Center for Bioethics at the University of Minnesota, directed by Jeff Kahn. I would like to thank all the Center faculty and staff for their direction and support during my years as a research assistant and especially in the last eighteen months as I returned to complete this dissertation. The Department of Philosophy also deserves my gratitude for a generous Swenson- Kierkegaard fellowship. Many family members and friends have helped along the way. Most of all, I would like to thank my husband Bill Vann whose love, friendship, and support not only made completing this project possible, but made it worthwhile. ii For my children Wilson, Willa, and Oscar iii Abstract This dissertation examines specific phenomena that illustrate a unique aspect of the role of patient activism in shaping the practice of medicine. Each chapter focuses on a specific example. The four examples are the rise of Morgellons disease, activism by sufferers of chronic Lyme disease, research subject activism, and the use of patients to market Paxil for social phobia.
    [Show full text]
  • Syllabus-And-Proceedings.Pdf
    Courses How to Expand Your Practice With Telepsychiatry Director: Jay H. Shore, M.D., M.P.H. Thursday, October 19, 2017 Faculty: Peter M. Yellowlees, M.D., Robert Lee Caudill, M.D., Steven Chan, M.D., M.B.A. Buprenorphine and Office-Based Treatment of Opioid Use Disorder EDUCATIONAL OBJECTIVE: Director: John A. Renner, M.D. At the conclusion of this session, the participant Faculty: Petros Levounis, M.D., M.A., Andrew J. should be able to: 1) Understand how to select an Saxon, M.D. appropriate model of telepsychiatry care and develop an integration plan for to match EDUCATIONAL OBJECTIVE: telepsychiatry model into a specific practice setting; At the conclusion of this session, the participant 2) Understand methods for adapting telepsychiatry should be able to: 1) Discuss the rationale and need into various health care environments and solutions for medication-assisted treatment (MAT) of opioid and best methods of successful integration of use disorder; 2) Apply the pharmacological telepsychiatry into psychiatric practice; and 3) characteristics of opioids in clinical practice; 3) Comprehend how national standards and guidelines Describe buprenorphine protocols for all phases of for telepsychiatry, clinical workflows, e-treatment treatment and for optimal patient/treatment team coordination, and APPS can be best adopted matching; 4) Describe the legislative and regulatory for the creation of telepsychiatric practice. requirements of office-based opioid pharmacotherapy; and 5) Discuss treatment issues SUMMARY: and management of opioid use disorder in Telepsychiatry, in the form of live interactive adolescents, pregnant women, and patients with videoconferencing, has reached maturity as a field acute and/or chronic pain.
    [Show full text]
  • Sawbones 369: the Parasite Delusion Published 25Th May 2021 Listen Here on Themcelroy.Family
    Sawbones 369: The Parasite Delusion Published 25th May 2021 Listen here on themcelroy.family Clint: Sawbones is a show about medical history, and nothing the hosts say should be taken as medical advice or opinion. It’s for fun. Can’t you just have fun for an hour and not try to diagnose your mystery boil? We think you’ve earned it. Just sit back, relax and enjoy a moment of distraction from that weird growth. You’re worth it. [theme music plays] Justin: Hello everybody, and welcome to Sawbones: a marital tour of misguided medicine. I’m your cohost, Justin McElroy [whispers] and I feel great. Sydnee: And I’m Sydnee McElroy. Justin: Friday, right? Sydnee: Yeah? Justin: Woo! Sydnee: Feeling good? You happy? Justin: Feeling good, feeling Friday. Got that sun outside. Sydnee: Yeah, this warm weather is— yes. It is— Justin: Energized. Got my D, got my C, that’s coffee. Sydnee: I’m growing plants outside again. Justin: Yeah! You said they’re starting to perk up a little bit, too. You were a little frustrated. Sydnee: I know, I was so worried. I was so worried my herbs were not responding well at the beginning of the season and I thought— there was the frost where I didn’t get them in and they got snowed on and oh, I thought they were done for. Justin: Yeah. Sydnee: But they’re growing again so all is well. They just had to chill? I don’t know. Justin: If you think it would be— Sydnee: [laughs] I don’t know anything about that.
    [Show full text]
  • Lyme Disease After My Teenage Daughter Became Very Ill with It
    A FACTUAL GUIDE BY THE WORLD'S LEADING CLINICAL EXPERT MORGELLONS: THE LEGITIMIZATION OF A DISEASE Dr. Ginger Savely Disclaimer: The information in this book is not intended as a substitute for medical counseling. The author does not assume liability for any loss, damage, or injury caused or alleged to be caused directly or indirectly by the information contained in or omitted from this book. Copyright © 2016 by Virginia Riley Savely Library of Congress Cataloging-in-Publication Data is available on file. All Rights Reserved. No part of this book may be reproduced in any manner without the express written consent of the author, except in the case of brief excerpts in critical reviews or articles. In an effort to keep sales prices down, this book has been printed in black and white. Please visit www.gingersavely.com/morgellons-book to access color versions of all photographs. Cover design by Ruben de Haas Cover photo credit Denise Moudree ISBN E-Book: 978-0-9979200-0-0 Pap erback: 978-0-9979200-2-4 Printed in the United States of America DEDICATION Travis Wilson was one of many “orphan patients” abandoned by the health care system because he did not have the good fortune to contract a known and socially accepted disease. To Travis, for the loss of his young life, and to the many other Morgellons patients who have suffered in isolation and fear, I dedicate this work. FOREWORD There is a rapidly growing interest in Morgellons disease as evidenced by the fact that research papers on the topic have been among the most highly accessed scientific research on the Internet for the past few years.
    [Show full text]
  • Troublesome Disguises Managing Challenging Disorders in Psychiatry
    Troublesome disguises Managing challenging disorders in psychiatry Troublesome disguises Managing challenging disorders in psychiatry EDITED BY Dinesh Bhugra Professor of Mental Health and Cultural Diversity Institute of Psychiatry, King’s College London London, UK Gin S. Malhi Professor and Chair Department of Psychiatry Sydney Medical School University of Sydney Sydney, Australia SECOND EDITION This edition first published 1997 © 2015 by John Wiley & Sons, Ltd. Registered Office John Wiley & Sons, Ltd, The Atrium, Southern Gate, Chichester, West Sussex, PO19 8SQ, UK Editorial Offices 9600 Garsington Road, Oxford, OX4 2DQ, UK The Atrium, Southern Gate, Chichester, West Sussex, PO19 8SQ, UK 1606 Golden Aspen Drive, Suites 103 and 104, Ames, Iowa 50010, USA For details of our global editorial offices, for customer services and for information about how to apply for permission to reuse the copyright material in this book please see our website at www.wiley.com/wiley-blackwell The right of the author to be identified as the author of this work has been asserted in accordance with the UK Copyright, Designs and Patents Act 1988. All rights reserved. No part of this publication may be reproduced, stored in a retrieval system, or transmitted, in any form or by any means, electronic, mechanical, photocopying, recording or otherwise, except as permitted by the UK Copyright, Designs and Patents Act 1988, without the prior permission of the publisher. Designations used by companies to distinguish their products are often claimed as trademarks. All brand names and product names used in this book are trade names, service marks, trademarks or registered trademarks of their respective owners.
    [Show full text]